These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12934343

  • 21. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.
    Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
    [Abstract] [Full Text] [Related]

  • 22. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 23. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
    Umeda N, Yoshikawa T, Kanazawa H, Hirata K, Fujimoto S.
    Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
    [Abstract] [Full Text] [Related]

  • 24. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 25. Beta agonist use during asthma exacerbations: how much is too much?
    Patel M, Perrin K, Beasley R.
    N Z Med J; 2011 Apr 15; 124(1332):77-80. PubMed ID: 21747427
    [Abstract] [Full Text] [Related]

  • 26. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar 15; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

  • 27. [Bronchial asthma -- to set the measuring rod higher. Combination therapy defines asthma control anew].
    MMW Fortschr Med; 2003 Nov 13; 145(46):46-7. PubMed ID: 14699833
    [No Abstract] [Full Text] [Related]

  • 28. The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD.
    Hanania NA, Kalberg C, Yates J, Emmett A, Horstman D, Knobil K.
    Pulm Pharmacol Ther; 2005 Nov 13; 18(1):19-22. PubMed ID: 15607123
    [Abstract] [Full Text] [Related]

  • 29. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 30. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
    Acad Emerg Med; 2007 Oct 12; 14(10):833-40. PubMed ID: 17898245
    [Abstract] [Full Text] [Related]

  • 31. [Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study].
    Seeger W, Schulz R.
    Internist (Berl); 2004 Jun 12; 45(6):727-8. PubMed ID: 15138641
    [No Abstract] [Full Text] [Related]

  • 32. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct 12; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 33. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
    Maltais F, Mahler DA, Pepin V, Nadreau E, Crater GD, Morris AN, Emmett AH, Ferro TJ.
    Eur Respir J; 2013 Aug 12; 42(2):539-41. PubMed ID: 23904549
    [No Abstract] [Full Text] [Related]

  • 34. Can beta agonists cause dilated cardiomyopathy?
    Choudhary AS, Robinson GM.
    Heart Lung Circ; 2009 Oct 12; 18(5):367-9. PubMed ID: 19081299
    [Abstract] [Full Text] [Related]

  • 35. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Virchow C.
    Dtsch Med Wochenschr; 2009 Dec 12; 134 Suppl 10():S376-80. PubMed ID: 19941240
    [No Abstract] [Full Text] [Related]

  • 36. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.
    Ann Intern Med; 2007 Apr 17; 146(8):I12. PubMed ID: 17310044
    [No Abstract] [Full Text] [Related]

  • 37. Management of interleukin-2-induced severe bronchoconstriction.
    Suda T, Hashizume H, Aoshima Y, Yokomura K, Sato J, Inui N, Nakamura Y, Fujisawa T, Enomoto N, Chida K.
    Eur Respir J; 2007 Mar 17; 29(3):612-3. PubMed ID: 17329497
    [No Abstract] [Full Text] [Related]

  • 38. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 17; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 39. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 40. Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist.
    Reddel HK, Gibson PG, Peters MJ, Wark PA, Sand IB, Hoyos CM, Jenkins CR.
    Respir Med; 2010 Aug 06; 104(8):1110-20. PubMed ID: 20430604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.